GLP-1 Medications Help Users Sustain Reduced Calorie Intake Beyond One Year, Review Finds

Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications that includes Ozempic and Wegovy, may help people maintain a lower daily calorie intake for more than a year, according to a recently published review. The findings add to a growing body of evidence examining how these drugs affect appetite, eating behaviour and long-term weight management.

What the review examined

Researchers looked at studies tracking caloric consumption among adults prescribed GLP-1 medications for weight loss or type 2 diabetes management. Across multiple trials, participants who stayed on the drugs consistently reported eating fewer calories than before treatment, and that reduced intake appeared to persist for at least 12 months in many cases.

Why sustained calorie reduction matters

One of the most stubborn challenges in weight management is not just losing weight but keeping it off. Traditional dieting often leads to metabolic adaptations that drive hunger and rebound weight gain. The review suggests that GLP-1 agonists may blunt those signals, helping users stay in a modest calorie deficit without constant feelings of deprivation.

Key points from the findings

• Calorie intake reductions were observed across multiple GLP-1 medications, not a single product.
• The behavioural effect appeared to last beyond 12 months in participants who continued treatment.
• Results reinforce earlier research on weight loss maintenance, including guidance on strategies for simultaneous fat loss and muscle growth.

Considerations and next steps

Experts caution that GLP-1 drugs are not a standalone solution. Nutrition quality, physical activity and medical supervision remain important, and side effects such as nausea can affect adherence. For readers curious about pairing medication with lifestyle changes, additional guidance on optimal morning nutrition and weight goals and on public figures' evolving routines, such as Heidi Klum's updated diet and workout plan, may offer practical context. Researchers say longer-term studies are still needed to confirm how durable these appetite-suppressing effects are beyond the first year.